Investing.com -- Entera Bio Ltd. (NASDAQ:ENTX) stock rose 3.5% in Thursday’s premarket trading following the company’s presentation of new clinical data from its Phase 2 trial of EB613, an oral ...
CAMBRIDGE, Mass. - 2seventy bio, Inc. (NASDAQ: TSVT), currently trading at $2.74 and showing significant volatility according to InvestingPro data, in partnership with Bristol Myers Squibb (BMS), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback